logo
Plus   Neg
Share
Email

Teva Canada Says Aermony RespiClick To Treat Bronchial Asthma Available In Three Dose Options

Teva Canada, a unit of Teva Pharmaceutical Industries Ltd. (TEVA), announced Monday the product availability of Aermony RespiClick, a new device for the treatment of bronchial asthma.

The new device is indicated for the maintenance treatment of steroid-responsive bronchial asthma as prophylactic therapy in patients 12 years of age and older and offered in a simple-to-use inhaler.

Aermony RespiClick is available in three dose options: 55 mcg, 113 mcg, and 232 mcg per actuation. It is dosed as one inhalation twice daily at the same time every day, approximately 12 hours apart.

Asthma is a chronic inflammatory disease of the airway that causes trouble breathing. Inhalers are the cornerstone of treatment, but, despite the potential benefits of inhaler therapy, evidence suggests that many patients do not use their inhalers correctly.

Anthony D'Urzo, a practising family physician and researcher at the University of Toronto, said, "Devices play a central role in the success of asthma therapy... Aermony RespiClick has desirable 'user-friendly' features that make it a welcome addition for patients who require maintenance therapy with a medication like fluticasone propionate."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Google parent Alphabet decided to drop its Internet balloon project Loon that was launched with the idea of providing Internet access to rural areas and providing last mile connectivity. In a blog post, Loon CEO Alastair Westgarth said they have not found a way to get the costs low enough to build a long-term, sustainable business, despite gaining a number of interested partners along the way. American Airlines announced the launch of Flagship Cellars, its home delivery service for premium wines usually available onboard. The airline's move is said to be due to the excess wine it has amid the weakness in air travel demand following the coronavirus pandemic crisis. The company expects the new at-home wine program to generate about $40,000 to $50,000 in sales during the first quarter. Intel Corp. is planning to manufacture majority of its 2023 products internally, while it may outsource some, according to the incoming Chief Executive Officer Pat Gelsinger. At the fourth-quarter earnings webcast, while talking about 7nm program development, Gelsinger said, "I am confident that the majority of our 2023 products will be manufactured internally...."
Follow RTT